'Am I supposed to put food on my family's table, or am I supposed to get weight loss medication?' Adrian, a 30-year-old systems engineer from Utah who asked that we withhold his last name for privacy reasons, was 372 pounds and caught in a maddening medical system loop last year
Recipient food intake during refeeding was then measured, but no significant difference was observed between the control and liraglutide-treated groups (Supplementary Fig
Complete your virtual consultation (purchased and scheduled through the shop)
Emerging evidence suggests that treatment with the dual GLP-1 and GIP receptor agonist, tirzepatide, might prove even more potent than a GLP-1RA alone, to ameliorate NAFLD
In phase 3 research, the participants taking the highest dose of retatrutide lost an average of about 28.7 percent of their body weight after about 68 weeks
Research Applications